CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
35,413
42,875
82,497
11,935
0
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Expenses
Research Development
66,174
62,736
49,495
37,945
33,183
Selling General and Administrative
22,815
20,409
16,509
14,710
14,506
Total Operating Expenses
88,989
83,145
66,004
52,655
47,689
Operating Income or Loss
-53,576
-40,270
16,493
-40,720
-47,689
Interest Expense
2,077
1,224
4
0
-
Total Other Income/Expenses Net
-
2,304
1,366
0
0
Income Before Tax
-50,746
-37,966
17,859
-39,963
-47,305
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-50,746
-37,966
17,859
-39,963
-47,305
Net Income
-50,746
-37,966
17,859
-39,963
-47,305
Net Income available to common shareholders
-50,746
-37,966
17,859
-39,963
-47,305
Reported EPS
Basic
-
-0.76
0.37
-0.86
-1.08
Diluted
-
-0.76
0.36
-0.86
-1.08
Weighted average shares outstanding
Basic
-
49,814
48,413
46,432
43,890
Diluted
-
49,814
49,615
46,432
43,890
EBITDA
-
-36,230
18,281
-39,615
-47,212